It was discovered in vitro that the CD3xPDL1 BiTE activates T cells as well as NKT cells from healthy donors and cancer patients, and that the activated cells were cytotoxic for multiple types of PD-L1 expressing human tumors [94]. This evidence concerns the gene CD274 and cancer.